Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Apax Global Alpha to invest further in WSGN

(Sharecast News) - Apax Global Alpha said in an update on Friday that it expects to invest a further €3m indirectly in WGSN, following the consumer trend forecaster's acquisition of IWSR, a provider of data and analytics for the alcoholic beverage industry. WGSN is a portfolio company of the Apax XI fund, in which Apax Global Alpha is a limited partner.

The FTSE 250 company said the acquisition of IWSR, which provides proprietary data from over 160 countries and had operated for more than four decades, was aimed at expanding WGSN's footprint in the beverage sector.

It said the deal would support WGSN's strategy of broadening its data analytics and forecasting capabilities across a range of consumer-focused industries.

Including the latest investment, Apax Global Alpha said it had committed around €24.7m to WGSN on a look-through basis.

The company holds an overall commitment of $700m to the Apax XI fund.

Apax Global Alpha, listed in London, provides exposure to Apax-advised private equity funds alongside a smaller portfolio of debt investments.

At 0822 BST, shares in Apax Global Alpha were up 0.18% at 113.81p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.